# US Human Milk Oligosaccharides Market

> US Human Milk Oligosaccharides Market Size, Share, Industry Trend & Analysis Research Report: By Application (Infant Formula, Functional Foods, Dietary Supplements), By Source (Human Milk, Synthetic Production, Animal Milk), By Form (Powder, Liquid, Capsules) andBy End Use (Healthcare, Food and Beverages, Nutraceuticals)- Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 14.28%
- **2024:** $ 121.8 Million
- **2025:** $ 139.19 Million
- **2035:** $ 528.76 Million
- **Key Players:** Nestle (CH), Danone (FR), Bifidobacterium (DE), FrieslandCampina (NL), Synlogic (US), Ginkgo Bioworks (US), Ferring Pharmaceuticals (CH), Evolva (CH)

**Report ID:** MRFR/FnB/13837-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-human-milk-oligosaccharides-market-15364

---

## Market Summary

## **US Human Milk Oligosaccharides Market Overview**

US Human Milk Oligosaccharides Market Size was estimated at 114.75 (USD Million) in 2023. The US Human Milk Oligosaccharides Market Industry is expected to grow from 130.5(USD Million) in 2024 to 562.5 (USD Million) by 2035. The US Human Milk Oligosaccharides Market CAGR (growth rate) is expected to be around 14.204% during the forecast period (2025 - 2035).

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Key US Human Milk Oligosaccharides Market Trends Highlighted**

The US Human Milk Oligosaccharides (HMOs) market is experiencing notable growth driven by an increasing awareness of the benefits of HMOs for infant health. Parents and caregivers are becoming more informed about the nutritional advantages HMOs provide, particularly in supporting gut health and enhancing immune responses in infants. This shift is supported by government initiatives promoting breastfeeding and maternal health, which emphasize the importance of natural ingredients in infant nutrition.

As research continues to uncover the positive impacts of HMOs on overall health, consumers are showing a preference for products enriched with these components, creating a fertile ground for market expansion.There are significant opportunities to be captured in the development of innovative HMO formulations tailored for various age groups and specific health needs. Products that incorporate HMOs into functional foods and dietary supplements present a unique avenue for brands looking to diversify their offerings. Additionally, the growing trend towards clean label products resonates with consumers who desire transparency in ingredient sourcing and formulation.

Manufacturers who can provide evidence-based formulations while maintaining high ethical standards can differentiate themselves in this burgeoning market. In recent times, the US market has seen increased investment in research and development focused on HMOs, creating momentum for future growth.Collaborations between food scientists, nutritionists, and health professionals are becoming more prevalent as companies seek to enhance the scientific backing for their products. Overall, the integration of HMOs into infant formulas and other related products is becoming a key trend, with a clear alignment with consumer preferences for health-centric and scientifically validated nutrition solutions.

## **US Human Milk Oligosaccharides Market Drivers**

### **Increasing Awareness of Health Benefits**

The rising awareness among consumers about the health benefits associated with Human Milk Oligosaccharides (HMOs) is driving growth in the US Human Milk Oligosaccharides Market Industry. HMOs play a crucial role in promoting gut health, enhancing immunity, and supporting brain development in infants.

The Centers for Disease Control and Prevention (CDC) reported that breastfeeding rates have increased in the US, with approximately 83% of infants being breastfed at some point, as per 2020 statistics.This enhancement in breastfeeding habits is expected to create a subsequent increase in demand for HMOs, with parents seeking fortified products that offer similar benefits to those found in breast milk. Furthermore, healthcare professionals are increasingly recommending HMOs in infant formulas, which is projected to boost the market further, considering that nearly 1 in 5 infants are formula-fed exclusively at six months of age.

These trends solidify the link between consumer awareness and market growth.

**Growing Demand for Infant Formulas Incorporating HMOs**

The increasing demand for infant formulas that incorporate Human Milk Oligosaccharides is significantly influencing the US Human Milk Oligosaccharides Market Industry. According to the American Academy of Pediatrics, approximately 70% of babies in the US consume infant formula by the age of three months. As parents seek to improve the nutritional profile of infant formulas, several prominent companies have launched products enriched with HMOs, which directly contribute to a healthier gut microbiome.For instance, leading infant formula manufacturers like Nestlé and Mead Johnson are integrating HMOs into their products, which promises potential benefits for infant health and development.

The market is expected to witness a surge as more parents opt for formulas that replicate the benefits of breastfeeding.

### **Advancements in Research and Development**

Ongoing advancements in Research and Development (R&D) related to Human Milk Oligosaccharides are acting as a key driver for the US Human Milk Oligosaccharides Market Industry. Significant investments from biotechnology firms have led to the discovery of various HMO types and their potential benefits. In 2022, the National Institutes of Health (NIH) noted a substantial increase in funding for studies focusing on HMOs, indicating a strong commitment to understanding their impact on health.Additionally, patents related to HMOs have increased by 25% over the last five years, demonstrating the growing interest in innovative applications.

These advancements not only foster market growth but also enhance consumer confidence in products containing HMOs, as scientific backing continues to emerge.

## **US Human Milk Oligosaccharides Market Segment Insights**

### **Human Milk Oligosaccharides Market Application Insights**

The Application segment of the US Human Milk Oligosaccharides Market encompasses various critical areas that cater to the increasing demand for health-focused products. This segment is experiencing significant growth, driven by an escalating awareness among consumers regarding the health benefits associated with Human Milk Oligosaccharides (HMOs). The Infant Formula category remains a key focus area, leveraging the beneficial properties of HMOs to mimic the composition of natural human breast milk, thereby enhancing infant growth and immunological development.

This focus on Infant Formula is vital as it addresses the nutritional gaps for infants who may not have access to breastfeeding, ensuring that they receive essential prebiotic benefits that support gut health and overall development.In the realm of Functional Foods, the use of HMOs is becoming increasingly recognized for enhancing the health profile of various food products. Consumers are actively seeking functional foods that contribute positively to their well-being, making this a dynamic area within the market.

The integration of HMOs into Functional Foods not only provides digestive health benefits but also promotes immune system support, which aligns with the growing trend toward preventive healthcare. This evolving trend is particularly relevant in the US, where health-conscious consumers are prioritizing food choices that offer added health benefits.Moreover, the Dietary Supplements category is gaining traction as more individuals look to supplements as a means of fortifying their diets with essential nutrients, including HMOs. This category is significant as it appeals to a broad audience, including parents looking to ensure their children's health and the elderly seeking gut health support.

The rising inclination toward self-care and wellness is fueling the demand for dietary products enriched with HMOs, reinforcing their role in a balanced diet.Overall, the Application segment for HMOs in the US reflects a robust landscape characterized by increasing consumer awareness and the pursuit of healthier lifestyles. Each area within this segment plays an essential role, addressing specific nutritional needs and responding to the evolving preferences of health-conscious consumers. The continuous innovation in product offerings across Infant Formula, Functional Foods, and Dietary Supplements is setting the stage for sustained market growth in the coming years.

The interplay between these categories and the overarching trend toward health and wellness signifies the importance of the Application segment in shaping the future of the US Human Milk Oligosaccharides Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Human Milk Oligosaccharides Market Source Insights**

The Source segment of the US Human Milk Oligosaccharides Market plays a crucial role in defining the market landscape, comprising various origins such as Human Milk, Synthetic Production, and Animal Milk. Human Milk remains a vital source as it naturally contains beneficial oligosaccharides that contribute to infant health and development, promoting gut health and immunity. This naturally derived segment is particularly significant due to the increasing recognition of its nutritional advantages and the growing preference for breastfeeding.

On the other hand, Synthetic Production is gaining traction as advancements in technology allow for the creation of oligosaccharides that mimic those found in human milk, providing a viable alternative for consumers seeking functional benefits without relying solely on human sources.Meanwhile, Animal Milk offers another avenue, appealing particularly to those who may not have direct access to human milk or prefer a dairy-based option.

The diversity within this Source segment illustrates the potential for expansive growth and adaptation in catering to various consumer preferences and nutritional needs, as the US Human Milk Oligosaccharides Market continues to evolve amidst changing dietary patterns and health consciousness among families.

### **Human Milk Oligosaccharides Market Form Insights**

The US Human Milk Oligosaccharides Market, particularly focusing on the Form segment, showcases significant diversity with its products categorized into various formats such as Powder, Liquid, and Capsules. This market has gained momentum due to the rising adoption of human milk oligosaccharides (HMOs) in infant nutrition and dietary supplements, emphasizing the growing consumer awareness regarding health benefits. The Powder form is recognized for its convenience and versatility, making it a prominent choice among parents for infant formula.

Meanwhile, the Liquid format is perceived as user-friendly, appealing to consumers seeking immediate use and easy incorporation into feeding routines.Capsules, on the other hand, cater to adults looking to benefit from the prebiotic effects of HMOs, highlighting the expanding applications beyond infant nutrition. Trends indicate robust demand driven by health-conscious consumers and increased recognition of the functional benefits associated with HMOs, including improved gut health and immune support.

Challenges remain in terms of regulatory hurdles and sourcing of high-quality ingredients, yet the opportunities for innovation and new product development in this thriving market segment remain substantial.Overall, the Form segment represents a crucial part of the overall US Human Milk Oligosaccharides Market, reflecting varied consumer preferences and enhancing market growth.

### **Human Milk Oligosaccharides Market End Use Insights**

The US Human Milk Oligosaccharides Market has shown significant growth potential, particularly within the End Use segment, which encompasses various applications such as Healthcare, Food and Beverages, and Nutraceuticals. As awareness about the health benefits of Human Milk Oligosaccharides increases, the Healthcare sector plays a crucial role by incorporating these compounds into infant formulas and therapeutic products aimed at enhancing gut health and immune response.

The Food and Beverages segment, meanwhile, is witnessing a rise in demand for functional foods enriched with Human Milk Oligosaccharides, aligning with consumer trends towards healthier eating habits and nutrition.Additionally, the Nutraceuticals sector is significant, with a growing focus on preventive healthcare and wellness products. This trend generates opportunities for innovation and product development, as brands look to leverage the unique properties of Human Milk Oligosaccharides for enhancing the nutritional profile of their offerings.

As these segments evolve, they contribute to a broader understanding of the importance of Human Milk Oligosaccharides in supporting health and well-being, addressing consumer needs for clean labels and scientifically backed ingredients that promote better health outcomes.

### **US Human Milk Oligosaccharides Market Key Players and Competitive Insights**

The US Human Milk Oligosaccharides Market is characterized by a growing demand for functional ingredients that enhance infant nutrition and promote health. This market is witnessing significant advancements driven by increased consumer awareness around the importance of gut health and immune function for infants. Companies are focusing on innovation and research to develop high-quality human milk oligosaccharides (HMOs) that are perceived as beneficial for both infants and their mothers. As this market continues to evolve, competitive insights reveal a landscape filled with both established players and emerging startups, all vying for a share in this lucrative field.

The interplay between technological advancements and regulatory aspects will shape the strategies employed by these companies to effectively position themselves within the market.Ginkgo BioWorks has established a significant presence in the US Human Milk Oligosaccharides Market, leveraging its strengths in synthetic biology to develop innovative oligosaccharide products. The company utilizes advanced genetic engineering techniques, allowing for the creation of tailored human oligosaccharides that meet the growing needs of the infant nutrition segment.

Ginkgo BioWorks has built strong partnerships and collaborations that enhance its research and development capabilities, subsequently leading to a robust pipeline of products aimed at addressing specific health benefits for infants. With a focus on quality and consistency, the company's strategic positioning and expertise in bioengineering enable it to cater to the rising demand for HMOs effectively.Tate and Lyle is a key player in the US Human Milk Oligosaccharides Market, recognized for its commitment to innovation and product development in the realm of nutritional ingredients.

The company offers a range of key products that focus on enhancing infant nutrition, including various HMOs that provide health benefits such as improved gut health and immune support. Tate and Lyle's strong market presence is bolstered by its ongoing research and development initiatives, which ensure the alignment of its products with consumer preferences and regulatory standards. The company's strategic focus on mergers and acquisitions has strengthened its position in the US market, allowing for expanded capabilities in the nutritional space.

This proactive approach to fostering innovation, coupled with an emphasis on sustainability, cements Tate and Lyle’s reputation as a leader in the human milk oligosaccharides sector, addressing the needs of both consumers and manufacturers across the country.

### **Key Companies in the US Human Milk Oligosaccharides Market Include**

- Ginkgo BioWorks
- Tate and Lyle
- PepsiCo
- Abbott Laboratories
- Nestle
- GeneXus
- Prolacta Bioscience
- [FrieslandCampina](https://www.frieslandcampina.com/milk/story-of-milk/)
- Nutribén
- Johnson and Johnson
- Bifidobacterium
- Danone
- Synlogic
- Finyou

### **US Human Milk Oligosaccharides Market Industry Developments**

Recent developments in the US Human Milk Oligosaccharides Market highlight significant growth and interest from major companies. Ginkgo BioWorks is focusing on biomanufacturing solutions to enhance the production of Human Milk Oligosaccharides, while Abbott Laboratories and Nestle continue to expand their product lines featuring these ingredients, aiming to cater to the growing demand for infant nutrition. In September 2023, Nielsen reported a substantial increase in demand for products containing Human Milk Oligosaccharides, indicating increasing consumer awareness about their benefits in infant formula.

Notable mergers include Tate and Lyle's acquisition of a smaller firm to boost its capabilities in functional sweeteners, relevant to the Human Milk Oligosaccharides market. Furthermore, FrieslandCampina and Prolacta Bioscience have been collaborating on Research and Development initiatives to advance the applications of Human Milk Oligosaccharides in health products, aligning with a broader trend towards enhancing infant health. The market valuation of US-based companies has seen upward trends, attributed to rising investments and innovations in this sector, emphasizing the significance of R&D and strategic partnerships.

In the last two years, increased consumer interest and regulatory support have further accelerated growth opportunities within this specialized market.

## **US Human Milk Oligosaccharides Market Segmentation Insights**

- **Human Milk Oligosaccharides Market Application****Outlook** - Infant Formula - Functional Foods - Dietary Supplements
- **Human Milk Oligosaccharides Market Form****Outlook** - Powder - Liquid - Capsules
- **Human Milk Oligosaccharides Market End Use****Outlook** - Healthcare - Food and Beverages - Nutraceuticals

## Market Drivers

### Expansion of E-commerce Platforms

The human milk-oligosaccharides market is being positively impacted by the expansion of e-commerce platforms. The convenience of online shopping has transformed consumer purchasing behaviors, particularly among parents seeking infant nutrition products. E-commerce allows for greater accessibility to specialized products containing human milk-oligosaccharides, which may not be readily available in traditional retail outlets. Recent statistics suggest that online sales of infant formula are projected to grow by over 15% annually, indicating a shift in consumer preferences. This trend not only facilitates market penetration for manufacturers but also enhances consumer awareness and education regarding the benefits of human milk-oligosaccharides, thereby driving overall market growth.

### Shift Towards Clean Label Products

The human milk-oligosaccharides market is benefiting from a significant shift towards clean label products. Consumers are increasingly seeking transparency in food labeling, preferring products that are free from artificial additives and preservatives. This trend is particularly pronounced among parents purchasing infant nutrition products, who prioritize natural ingredients. As a response, manufacturers are reformulating their products to include human milk-oligosaccharides, which are perceived as a natural and beneficial ingredient. This shift is reflected in market data, indicating that clean label products are expected to capture a larger share of the infant formula market, potentially reaching 30% by 2026. Such developments suggest that the human milk-oligosaccharides market is well-positioned to thrive in this evolving landscape.

### Growing Demand for Infant Nutrition

The human milk-oligosaccharides market is experiencing a notable surge in demand driven by the increasing focus on infant nutrition. Parents are becoming more aware of the nutritional benefits associated with human milk-oligosaccharides, which are known to support immune function and gut health in infants. According to recent data, the infant formula segment, which incorporates these oligosaccharides, is projected to grow at a CAGR of approximately 8% over the next five years. This growth reflects a broader trend towards premium infant nutrition products, as parents seek to provide the best possible start for their children. Consequently, manufacturers are expanding their product lines to include human milk-oligosaccharides, thereby enhancing their market presence and catering to the evolving preferences of health-conscious consumers.

### Rising Health Consciousness Among Consumers

The human milk-oligosaccharides market is experiencing growth due to rising health consciousness among consumers. As awareness of the importance of gut health and immune support increases, parents are more inclined to choose products that contain beneficial ingredients like oligosaccharides. This trend is particularly evident in the U.S., where health-focused marketing strategies are gaining traction. Data indicates that products enriched with human milk-oligosaccharides are perceived as superior, leading to higher sales in the infant nutrition sector. The increasing emphasis on preventive health measures is likely to further bolster the demand for these products, positioning the human milk-oligosaccharides market for sustained growth in the coming years.

### Increased Research and Development Activities

The human milk-oligosaccharides market is significantly influenced by heightened research and development activities. Scientific studies continue to unveil the health benefits of oligosaccharides, including their role in promoting gut microbiota and reducing the risk of infections in infants. As a result, companies are investing heavily in R&D to innovate and develop new products that incorporate these beneficial compounds. The U.S. market has seen a rise in collaborations between academic institutions and industry players, leading to advancements in oligosaccharide extraction and formulation techniques. This focus on innovation not only enhances product efficacy but also drives consumer interest, thereby contributing to the overall growth of the human milk-oligosaccharides market.

## Future Outlook

The [Human Milk Oligosaccharides Market](https://www.marketresearchfuture.com/reports/human-milk-oligosaccharides-market-7843) is projected to grow at a 14.28% CAGR from 2025 to 2035, driven by increasing consumer awareness and demand for infant nutrition.

**New opportunities:**

- Development of customized HMO blends for specific health conditions.
- Expansion into e-commerce platforms for direct consumer sales.
- Partnerships with healthcare providers for product recommendations.

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Application: Infant Formula (Largest) vs. Functional Foods (Fastest-Growing)

In the US human milk-oligosaccharides market, the application segment showcases a diverse distribution, with Infant Formula holding the largest market share. This segment is preferred by consumers due to its critical role in infant nutrition and its growing acceptance among parents. Functional Foods follow as a notable contender, reflecting a significant uptake among health-conscious consumers seeking to enhance their diets through enhanced nutritional options.

The growth trends indicate that while Infant Formula continues to dominate, Functional Foods are quickly emerging as the fastest-growing segment. This growth is driven by increasing awareness of health benefits associated with oligosaccharides, coupled with rising demand for fortified food products. Additionally, the expansion of dietary supplements is contributing to the overall positive outlook for the segment, as more consumers discover the advantages of incorporating these products into their daily routines.

Infant Formula: Dominant vs. Dietary Supplements: Emerging

Infant Formula remains the dominant segment in the US human milk-oligosaccharides market, characterized by its established presence and strong consumer trust. This segment benefits from extensive research and development, resulting in tailored formulations that cater to the nutritional needs of infants. On the other hand, Dietary Supplements represent an emerging segment, gaining traction as consumers increasingly seek additional health benefits from their diets. These supplements are often marketed for their immune-boosting properties and overall gut health, appealing particularly to parents concerned about their children's nutritional intake. Both segments reflect a growing inclination towards improved health outcomes, albeit with differing target demographics and marketing strategies.

### By Source: Human Milk (Largest) vs. Synthetic Production (Fastest-Growing)

The market share distribution in the US human milk-oligosaccharides market shows that Human Milk holds a significant portion, indicating its established preference among consumers, primarily due to its natural origin and nutritional benefits. Synthetic Production, while currently smaller in share, is gaining traction and is projected to expand due to advancements in biotechnology and increased consumer acceptance of lab-made ingredients.

Growth trends indicate a rising demand for Human Milk as it is viewed as the most beneficial source for infants. However, the innovations in Synthetic Production are leading to rapid growth in this segment, driven by improvements in production technology and the ability to provide a more sustainable and cost-effective solution. This shift is expected to reshape preferences and market dynamics in the coming years.

Human Milk: Dominant vs. Synthetic Production: Emerging

Human Milk remains the dominant source in the US human milk-oligosaccharides market, celebrated for its extensive health benefits and suitability for infant nutrition. It is derived directly from breastfeeding mothers, making it highly preferred by health-conscious parents. On the other hand, Synthetic Production represents an emerging segment that leverages biotechnology to create oligosaccharides that mimic those found in human milk. This approach caters to a growing consumer base seeking alternatives that are both effective and sustainable, appealing especially to those concerned about the environmental impact of traditional production methods. As such, the evolution of these sources is pivotal in shaping the future landscape of the market.

### By Form: Powder (Largest) vs. Liquid (Fastest-Growing)

The US human milk-oligosaccharides market exhibits a diverse distribution in its 'Form' segment, where Powder products hold the largest market share. Powdered human milk-oligosaccharides are preferred for their convenience and ease of transport, catering to both consumers and manufacturers. Liquid formulations, while smaller in market share, are gaining traction due to their ready-to-use nature, appealing to consumers seeking quick and effective solutions.

In terms of growth trends, Liquid products are experiencing rapid expansion, driven by the increasing demand for convenient feeding solutions among busy parents. The rising awareness about the health benefits of human milk-oligosaccharides is further propelling the market for these liquid forms. Concurrently, the Powder segment remains a dominant force due to its established presence and consumer trust, though it faces competition from innovative liquid formulations.

Powder (Dominant) vs. Liquid (Emerging)

Powdered human milk-oligosaccharides occupy a dominant position in the market, characterized by their long shelf life and versatile application in various food products. These powdered forms are widely used in infant formulas and nutritional supplements, making them a staple choice among manufacturers. Meanwhile, Liquid formulations are emerging as an attractive alternative, providing instant usability that appeals to modern parents. The popularity of Liquid products is rising due to the ease of serving and the growing trend for on-the-go nutrition. Both segment values reflect the evolving consumer preferences in the US human milk-oligosaccharides market, balancing convenience with traditional usage.

### By End Use: Healthcare (Largest) vs. Food and Beverages (Fastest-Growing)

In the US human milk-oligosaccharides market, the healthcare segment holds the largest market share, driven by the increasing recognition of health benefits associated with oligosaccharides, particularly for infant nutrition and gut health. The food and beverages sector is rapidly gaining traction, appealing to adults looking for functional foods, which suggests a growing consumer awareness of the advantages of these components in everyday diets.

Growth trends indicate that consumer demand for health-oriented products continues to rise, especially as more studies underscore the importance of oligosaccharides in immune support and gut microbiome enhancement. Moreover, the expansion of e-commerce and innovative product formulations in the food and beverage space contribute significantly to the growth velocity of this segment, making it a focal point for manufacturers looking to capitalize on evolving market dynamics.

Healthcare: Healthcare (Dominant) vs. Food and Beverages (Emerging)

The healthcare segment is characterized by its established position amidst robust demand for infant nutritional products, leveraging the proven benefits of human milk-oligosaccharides. It appeals primarily to parents seeking optimal nutrition for their children, positioning itself as a trusted choice in pediatric health. Conversely, the food and beverages segment is emerging as a key player, driven by innovation and consumer shifts towards health-focused food options. This segment is attracting companies eager to explore new product lines that enhance dietary habits. The adaptability of oligosaccharides in various formulations allows for greater consumer access, driving interest and growth, particularly among health-conscious adults.

## Competitive Benchmarking

The human milk-oligosaccharides market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding the health benefits of oligosaccharides, particularly in infant nutrition. Key players such as Nestle (CH), Danone (FR), and Ginkgo Bioworks (US) are actively shaping the market through innovative product offerings and strategic partnerships. Nestle (CH) has positioned itself as a leader in the sector by focusing on research and development, particularly in the formulation of infant formulas enriched with human milk oligosaccharides. Meanwhile, Danone (FR) emphasizes sustainability in its operations, aiming to enhance its product portfolio with environmentally friendly practices. Ginkgo Bioworks (US) leverages its synthetic biology capabilities to develop novel oligosaccharide products, indicating a trend towards biotechnological advancements in the market.In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and enhance responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like FrieslandCampina (NL) and Synlogic (US) suggests a trend towards consolidation, as these firms seek to optimize their operations and expand their geographic reach.

In October  FrieslandCampina (NL) announced a strategic partnership with a leading biotechnology firm to enhance its research capabilities in human milk oligosaccharides. This collaboration is expected to accelerate the development of innovative products, thereby strengthening FrieslandCampina's market position. The strategic importance of this partnership lies in its potential to leverage cutting-edge research, which could lead to the introduction of new, differentiated products that meet evolving consumer preferences.

In September  Synlogic (US) launched a new product line that incorporates human milk oligosaccharides aimed at improving gut health in infants. This move not only diversifies Synlogic's product offerings but also aligns with the growing consumer demand for functional foods. The introduction of this product line is significant as it reflects a broader trend towards health-focused nutrition, which is likely to resonate well with health-conscious parents.

In August  Ginkgo Bioworks (US) secured a multi-million dollar investment to expand its production capabilities for human milk oligosaccharides. This investment is poised to enhance Ginkgo's ability to meet increasing market demand while also positioning the company as a key player in the biomanufacturing space. The strategic importance of this expansion lies in its potential to improve supply chain reliability and reduce production costs, thereby enhancing Ginkgo's competitive edge.

As of November  the competitive trends in the human milk-oligosaccharides market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing operational efficiencies. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to those focused on innovation, technological advancements, and supply chain reliability, suggesting a transformative shift in how companies compete in this evolving market.

## Recent News & Developments

Recent developments in the US Human Milk Oligosaccharides Market highlight significant growth and interest from major companies. Ginkgo BioWorks is focusing on biomanufacturing solutions to enhance the production of Human Milk Oligosaccharides, while Abbott Laboratories and Nestle continue to expand their product lines featuring these ingredients, aiming to cater to the growing demand for infant nutrition. In September 2023, Nielsen reported a substantial increase in demand for products containing Human Milk Oligosaccharides, indicating increasing consumer awareness about their benefits in infant formula.

Notable mergers include Tate and Lyle's acquisition of a smaller firm to boost its capabilities in functional sweeteners, relevant to the Human Milk Oligosaccharides market. Furthermore, FrieslandCampina and Prolacta Bioscience have been collaborating on Research and Development initiatives to advance the applications of Human Milk Oligosaccharides in health products, aligning with a broader trend towards enhancing infant health. The market valuation of US-based companies has seen upward trends, attributed to rising investments and innovations in this sector, emphasizing the significance of R&D and strategic partnerships.

In the last two years, increased consumer interest and regulatory support have further accelerated growth opportunities within this specialized market.

## Report Scope

| MARKET SIZE 2024 | 121.8(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 139.19(USD Million) |
| MARKET SIZE 2035 | 528.76(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.28% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Nestle (CH), Danone (FR), Bifidobacterium (DE), FrieslandCampina (NL), Synlogic (US), Ginkgo Bioworks (US), Ferring Pharmaceuticals (CH), Evolva (CH) |
| Segments Covered | Application, Source, Form, End Use |
| Key Market Opportunities | Growing demand for infant nutrition products enhances opportunities in the human milk-oligosaccharides market. |
| Key Market Dynamics | Rising consumer demand for infant nutrition drives innovation in human milk-oligosaccharides formulations and applications. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US human milk-oligosaccharides market?**
A: The market valuation was $121.8 Million in 2024.

**Q: What is the projected market size for the US human milk-oligosaccharides market by 2035?**
A: The market is projected to reach $528.76 Million by 2035.

**Q: What is the expected CAGR for the US human milk-oligosaccharides market during the forecast period 2025 - 2035?**
A: The expected CAGR is 14.28% during the forecast period.

**Q: Which companies are the key players in the US human milk-oligosaccharides market?**
A: Key players include Nestle (CH), Danone (FR), and FrieslandCampina (NL), among others.

**Q: What are the main application segments in the US human milk-oligosaccharides market?**
A: Main application segments include Infant Formula, Functional Foods, and Dietary Supplements.

**Q: How did the Infant Formula segment perform in 2024?**
A: The Infant Formula segment was valued between $40.0 Million and $180.0 Million in 2024.

**Q: What is the valuation range for the Synthetic Production source segment?**
A: The Synthetic Production source segment was valued between $50.0 Million and $250.0 Million in 2024.

**Q: What forms of human milk-oligosaccharides are available in the market?**
A: Available forms include Powder, Liquid, and Capsules.

**Q: What was the market valuation for the Food and Beverages end-use segment in 2024?**
A: The Food and Beverages end-use segment was valued between $45.72 Million and $200.0 Million in 2024.

**Q: How does the market for human milk-oligosaccharides appear to be evolving?**
A: The market appears to be growing rapidly, with a projected increase in valuation and a strong CAGR.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-human-milk-oligosaccharides-market-15364*